Kirk Rosemark
Conseiller Juridique Général chez XENCOR, INC.
Profil
Kirk Rosemark is currently working as the SVP-Regulatory Affairs & Quality Assurance at Xencor, Inc. Previously, he held positions as the VP-Regulatory Affairs & Quality Assurance at NeoPharm, Inc. and Exelixis, Inc. from 2003 to 2014.
From 2015 to 2017, he worked as the VP-Regulatory Affairs & Quality Assurance at CymaBay Therapeutics, Inc. and from 2017 to 2019, he served as the Vice President-Regulatory Affairs at BeiGene USA, Inc. Mr. Rosemark completed his undergraduate degree at Cleveland State University.
Postes actifs de Kirk Rosemark
| Sociétés | Poste | Début |
|---|---|---|
| XENCOR, INC. | Conseiller Juridique Général | - |
Anciens postes connus de Kirk Rosemark
| Sociétés | Poste | Fin |
|---|---|---|
BeiGene USA, Inc.
 BeiGene USA, Inc. Pharmaceuticals: MajorHealth Technology BeiGene USA, Inc. engages in pharmaceutical development. The company is headquartered in Cambridge, MA. | Conseiller Juridique Général | 01/06/2019 |
| CYMABAY THERAPEUTICS, INC. | Conseiller Juridique Général | 01/04/2017 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/11/2014 |
NeoPharm, Inc.
 NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Conseiller Juridique Général | 01/01/2014 |
Formation de Kirk Rosemark
| Cleveland State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Health Technology |
BeiGene USA, Inc.
BeiGene USA, Inc. Pharmaceuticals: MajorHealth Technology BeiGene USA, Inc. engages in pharmaceutical development. The company is headquartered in Cambridge, MA. | Health Technology |
